tiprankstipranks
AnaptysBio Inc (ANAB)
NASDAQ:ANAB
US Market

AnaptysBio (ANAB) Income Statement

Compare
379 Followers

AnaptysBio Income Statement

Last quarter (Q3 2024), AnaptysBio's total revenue was $30.02M, an increase of 804.67% from the same quarter last year. In Q3, AnaptysBio's net income was $-32.85M. See AnaptysBio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 17.16M$ 10.29M$ 63.17M$ 75.00M$ 8.00M
Gross Profit
$ 14.78M$ 7.95M$ -35.32M$ -5.03M$ -91.34M
Operating Expenses
$ 181.57M$ 125.44M$ 119.99M$ 98.88M$ 115.43M
Depreciation and Amortization
$ 2.38M$ 2.33M$ 2.09M$ 559.00K$ 514.00K
EBITDA
$ -143.16M$ -105.26M$ -55.71M$ -19.37M$ -95.93M
Operating Income
$ -164.41M$ -115.15M$ -56.81M$ -23.88M$ -107.43M
Other Income/Expenses
$ 788.00K$ -13.55M$ -982.00K$ 3.95M$ 9.94M
Pretax Income
$ -163.62M$ -128.70M$ -57.80M$ -19.93M$ -97.49M
Net Income
$ -163.62M$ -128.72M$ -57.19M$ -19.92M$ -97.34M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -6.08$ -4.57$ -2.08$ -0.73$ -3.60
Diluted EPS
$ -6.08$ -4.57$ -2.08$ -0.73$ -3.60
Weighted Average Shares Outstanding
26.92M 28.16M 27.43M 27.30M 27.06M
Weighted Average Shares Outstanding (Diluted)
26.92M 28.16M 27.43M 27.30M 27.06M
Currency in USD

AnaptysBio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis